Myosana Therapeutics
PrivateLast Round
Crowdfunding
Nov 13, 2025
Est. Valuation
$27.38M
Total Funding Raised
$6.35M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Myosana Therapeutics is a biotechnology company that develops a muscle-specific non-viral gene therapy platform for the treatment of neuromuscular and cardiac diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myosana Therapeutics Comparables
Compare Myosana Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spot Biosystems | 88% | |
| Orphina Biotechnology | 86% | |
| Kinea Bio, Inc. | 81% |
Myosana Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Nov 13, 2025 | ||||
| Seed | Jan 25, 2023 | ||||
| Grant | Aug 26, 2021 | ||||
| Seed | Apr 22, 2020 |
Myosana Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CureDuchenne Ventures | Seed, Crowdfunding |
| Parent Project Muscular Dystrophy | Grant, Seed, Crowdfunding |
| Muscular Dystrophy Association | Seed, Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 150% MoM.
- May 13, 2026
Monthly visitors increased 37% MoM.
Myosana Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Myosana Therapeutics's valuation, stock price, and market status.
Is Myosana Therapeutics a public or private company?
Myosana Therapeutics is a private company.
What is the current stock price of Myosana Therapeutics?
Myosana Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Myosana Therapeutics worth (valuation)?
Valuation information for Myosana Therapeutics is not publicly available.
Can I buy Myosana Therapeutics stock?
Myosana Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Myosana Therapeutics's last funding round?
Myosana Therapeutics's most recent funding round was SAFE on November 13, 2025.
Who are the main investors in Myosana Therapeutics?
Key investors in Myosana Therapeutics include CureDuchenne Ventures.
Will Myosana Therapeutics IPO soon?
No public IPO plans have been announced for Myosana Therapeutics.
How can I track Myosana Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Myosana Therapeutics's secondary market activity and sign up for updates.